Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 6,732 results for: pAAV

Clear keywords
Showing: 6421 - 6440 of 6732 results

  8. dTomato_LD 0_CS G_tTA-BFP

    Plasmid
    #58871
    Purpose
    MESA target chain with dTomato ectodomain, no linker domain, G cleavage sequence, and tTA-BFP fusion
    Depositor
    Joshua Leonard
    Article
    Daringer et al ACS Synth Biol. 2014 Mar 11.
    Insert
    MESA target chain with dTomato ectodomain, cd28 transmembrane domain, wild type TEV cleavage sequence
    Use
    AAV
    Tags
    EBFP
    Expression
    Mammalian
    Promoter
    CMV
    Available Since
    Nov. 3, 2014
    Availability
    Academic Institutions and Nonprofits only
    58871-plasmid-map-sequence-id-94232

    Enlarge

  13. Syn-ChR-tdTomato

    Plasmid
    #99843
    Purpose
    AAV expression of ChR2(H134R)-tdTomato under the Syn promoter
    Depositor
    Gordon Shepherd
    Insert
    ChR2(H134R)-tdTomato
    Use
    AAV
    Tags
    tdTomato
    Expression
    Mammalian
    Mutation
    ChR2(H134R), carrying a single point mutation at …
    Promoter
    human synapsin I promoter
    Available Since
    Jan. 26, 2018
    Availability
    Academic Institutions and Nonprofits only
    99843-plasmid-map-sequence-id-202528

    Enlarge

  14. pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag (AAV5)

    Viral Prep
    #209658-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag (#209658). In addition to the viral particles, you will also receive purified pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag plasmid DNA. CAG-driven, Cre-dependent expression of cpSFGFP.HaloTag (non-responsive control). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tim Brown, HHMI-JRC Tool Translation Team
    Article
    Marvin et al Proc Natl Acad Sci U S A. 2024 May 21;12
    Promoter
    CAG
    Tags
    SFGFP
    Available Since
    Oct. 29, 2025
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV.CAG.Flex.Ruby2sm-Flag.WPRE.SV40 (AAV5)

    Viral Prep
    #98928-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.CAG.Flex.Ruby2sm-Flag.WPRE.SV40 (#98928). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.Ruby2sm-Flag.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent expression of Ruby2sm-Flag spaghetti monster construct. Spaghetti monster constructs are not fluorescent ("dark") to allow full range of antibody staining. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Article
    Viswanathan et al Nat Methods. 2015 Jun;12(6):568-76. doi:
    Promoter
    CAG
    Tags
    mRuby2sm-Flag (spaghetti monster construct)
    Available Since
    Oct. 29, 2025
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV.TBG.PI.FLPo.rBG (AAV8)

    Viral Prep
    #236288-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.TBG.PI.FLPo.rBG (#236288). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.FLPo.rBG plasmid DNA. TBG-driven expression of the recombinase FLPo. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Melina Fan, Addgene Research Program
    Promoter
    TBG
    Available Since
    Oct. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV_BiCHATe27_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213833-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 29, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV_BiLAMP5e3_ChR2_mCherry (AAV1)

    Viral Prep
    #213915-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiLAMP5e3_ChR2_mCherry (#213915). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV_BiVIPe4_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213859-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV_BiSSTe10_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213818-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 6421 - 6440 of 6732 results